Arcadia Biosciences (RKDA) Invested Capital (2016 - 2025)
Arcadia Biosciences (RKDA) has disclosed Invested Capital for 12 consecutive years, with $5.4 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Invested Capital fell 46.37% year-over-year to $5.4 million, compared with a TTM value of $5.4 million through Sep 2025, down 46.37%, and an annual FY2024 reading of $6.2 million, down 51.01% over the prior year.
- Invested Capital was $5.4 million for Q3 2025 at Arcadia Biosciences, up from $4.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $45.7 million in Q1 2021 and bottomed at $4.5 million in Q2 2025.
- Average Invested Capital over 5 years is $20.2 million, with a median of $16.7 million recorded in 2023.
- The sharpest move saw Invested Capital skyrocketed 273.63% in 2021, then crashed 60.81% in 2025.
- Year by year, Invested Capital stood at $31.3 million in 2021, then tumbled by 32.99% to $20.9 million in 2022, then crashed by 39.36% to $12.7 million in 2023, then crashed by 51.01% to $6.2 million in 2024, then fell by 12.53% to $5.4 million in 2025.
- Business Quant data shows Invested Capital for RKDA at $5.4 million in Q3 2025, $4.5 million in Q2 2025, and $8.9 million in Q1 2025.